KLAC KLA CORP
Optical Instruments & Lenses · Nasdaq · SEC CIK 319201 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY15.8%
TTM net income YoY24.1%
TTM EPS YoY227.9%
Revenue 3-yr CAGR12.6%
Net income 3-yr CAGR19.2%
Margins
Gross margin61.5%
Operating margin—
Net margin36.2%
FCF margin27.8%
EBITDA margin—
Returns
ROE91.4%
ROA30.3%
ROIC (approx.)—
Asset turnover0.84x
Leverage & solvency
Liabilities / assets64.6%
Debt / equity0.88x
Current ratio2.76x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.86x
Accruals ratio4.3%
Payout ratio21.1%
Capex / revenue3.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $13.58B | $12.16B |
| Cost of revenue | $5.26B | $4.75B |
| Gross profit | $8.32B | $7.40B |
| R&D expense | $1.53B | $1.36B |
| SG&A expense | $1.13B | $1.03B |
| Interest expense | $284.44M | $302.17M |
| Pretax income | $5.61B | $4.64B |
| Income tax | $775.15M | $582.80M |
| Net income | $4.83B | $4.06B |
| EPS (basic) | 3.68 | 3.05 |
| EPS (diluted) | 3.66 | 3.04 |
| Dividends declared per share | 0.80 | 0.68 |
| Weighted avg. shares (diluted) | 1.32B | 1.34B |
| Balance sheet | ||
| Cash & equivalents | $1.65B | $2.08B |
| Receivables | $2.89B | $2.26B |
| Inventory | $3.65B | $3.21B |
| Current assets | $12.38B | $10.70B |
| PP&E, net | $1.38B | $1.25B |
| Goodwill | $1.79B | $1.79B |
| Intangibles | $255.84M | $444.79M |
| Total assets | $17.95B | $16.07B |
| Current liabilities | $4.30B | $4.09B |
| Short-term debt | — | $0 |
| Long-term debt | $5.89B | $5.88B |
| Total debt | $5.89B | $5.88B |
| Total liabilities | $11.60B | $11.38B |
| Shareholders' equity | $6.35B | $4.69B |
| Net debt | $4.24B | $3.81B |
| Shares outstanding | 1.31B | 1.32B |
| Cash flow statement | ||
| Operating cash flow | $4.14B | $4.08B |
| Capital expenditure | $375.94M | $335.26M |
| Free cash flow | $3.77B | $3.75B |
| Investing cash flow | -$1.19B | -$202.48M |
| Financing cash flow | -$3.39B | -$3.79B |
| Depreciation & amortization | $393.98M | $394.09M |
| Stock-based compensation | $310.17M | $265.01M |
| Dividends paid | $1.06B | $904.59M |
| Share buybacks | $2.29B | $2.15B |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.